Literature DB >> 14675602

Anti-neuronal autoantibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients.

Takashi Oide1, Takahiko Tokuda, Masahide Yazaki, Megumi Watarai, Shigeaki Mitsuhashi, Kazuma Kaneko, Takao Hashimoto, Shinji Ohara, Shu-ichi Ikeda.   

Abstract

Hashimoto's encephalopathy (HE) is thought to be caused by disorders of immune mechanisms. Although immunologically mediated central nervous system vasculitis or unidentified anti-neuronal autoantibodies have been suspected of causing HE, its pathogenesis is still unclear. For the study presented here, two patients with typical clinical and laboratory/electrophysiological findings of HE were analyzed to clarify the role of anti-neuronal autoantibodies in the pathogenesis of HE. The autopsied brain of one of the patients was histopathologically examined. For Western blotting analysis and immunohistochemistry, serum and purified immunoglobulin G obtained from the other patient were used. Autopsy revealed no evidence of central nervous system vasculitis or other abnormal findings in the brain. The patient's serum contained an anti-neuronal autoantibody that immunohistochemically labeled neurons of mouse and human cerebral cortices and reacted with the 36-kDa antigenic protein present in a soluble fraction obtained from human cerebral cortex. Our results indicate that anti-neuronal autoantibodies may be associated with the pathogenesis of HE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675602     DOI: 10.1016/j.jns.2003.08.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  28 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy).

Authors:  Gianluca Tamagno; Giovanni Federspil; Giovanni Murialdo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  Hashimoto encephalopathy: a do-not-miss in the differential diagnosis of dementia.

Authors:  Claire J Creutzfeldt; Roman L Haberl
Journal:  J Neurol       Date:  2005-06-13       Impact factor: 4.849

4.  Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. One autopsy case.

Authors:  P Striano; M Pagliuca; V Andreone; F Zara; A Coppola; S Striano
Journal:  J Neurol       Date:  2005-11-22       Impact factor: 4.849

Review 5.  The neurological disorder associated with thyroid autoimmunity.

Authors:  Franco Ferracci; Antonio Carnevale
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

Review 6.  Hashimoto's encephalopathy : epidemiology, pathogenesis and management.

Authors:  Ramon Mocellin; Mark Walterfang; Dennis Velakoulis
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Progressive impairment of cognition and motor function: Hashimoto encephalopathy.

Authors:  Peter Tzakas; Sze Wan Sit
Journal:  CMAJ       Date:  2011-02-14       Impact factor: 8.262

8.  Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series.

Authors:  Farrah J Mateen; Keith A Josephs; Joseph E Parisi; Daniel A Drubach; Richard J Caselli; Kejal Kantarci; Clifford Jack; Bradley F Boeve
Journal:  Neurocase       Date:  2011-06-30       Impact factor: 0.881

9.  Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes.

Authors:  Gianluca Tamagno; Yahya Celik; Rafael Simó; Marcel Dihné; Kazumi Kimura; Giorgio Gelosa; Byung I Lee; Caroline Hommet; Giovanni Murialdo
Journal:  BMC Neurol       Date:  2010-04-28       Impact factor: 2.474

10.  Steroid-responsive recurrent encephalopathy associated with subacute thyroiditis.

Authors:  Yun Jae Chung; Kwang-Yeol Park; Jihyun Ahn; Sam-Yeol Ha; Young Chul Youn
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.